Do learn the massive difference between peer reviewed research and editorial opinion/promotion pieces Gavin. Perhaps AI can help you again.
And no, the link you posted was NOT "reported from The Advanced Therapies Europe Conference". It was a follow up promotional piece for Catalent to a panel discussion therein, that the company representatives simply featured in. If you actually had the vaguest idea on CYP (MSB) or the stem cell industry in general, you'd know they were a smaller manufacturer and research facilities company that facilitates (and occasionally partners) with companies across a variety of cellular treatments. They are not even particularly re-known at IPSC's, let alone the leading experts.
In fact, Lonza (you know MSB's manufacturing partner) has a more extensive offering in GMP-compliant iPSC manufacturing.
I look forward to your next AI inspired attempt at lighting a fire under CYP/IPSC's with a some more crappy kindling. At least you are learning along the way. Yawn.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)